Cincinnati Children's Hospital Medical Center: Researchers Find Best Way to Treat Children With Sickle Cell Anemia in Sub-Saharan Africa
June 25, 2020
June 25, 2020
CINCINNATI, Ohio, June 25 -- The Cincinnati Children's Hospital Medical Center issued the following news release:
A team of international researchers has learned that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective and has similar side effects than a lower fixed dose of the same drug.
The study, known as NOHARM MTD (Novel use Of Hydroxyurea in an African Region with Malaria - Maximum Tolerated Dose), focused . . .
A team of international researchers has learned that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective and has similar side effects than a lower fixed dose of the same drug.
The study, known as NOHARM MTD (Novel use Of Hydroxyurea in an African Region with Malaria - Maximum Tolerated Dose), focused . . .